With Pandemic Easing, Bristol Myers Squibb Takes Its GRYT-Partnered Digital Advocacy Group Beyond COVID-19

As many COVID-inspired pharma efforts taper off, at least one initiative born during the pandemic is going strong—and dropping the pandemic moniker to evolve even further.

Bristol Myers Squibb’s patient advocacy partnership with GRYT Health is changing its name from the COVID Advocacy Exchange to simply the Advocacy Exchange. The name change shows that the global online service platform for patient advocates and patients is moving from a COVID-19 resource to an everyday one.